.png
)
May 5, 2020 Manufacturing Quality Branch (MQB), Therapeutic Goods Administration (TGA), Australia has notified that they are intending to adopt the current version of the PIC/S Guide to Good Manufacturing Practice for Medicinal Products (PE009-14) issued, 1 July 2018, as…
May 1, 2020 Central Drugs Standard Control Organization (CDSCO), the Government of India Drug Regulatory Agency has extended the validity of WHO GMP/ Certificate of Pharmaceutical Product (COPP) expiring from March 2020 to August 2020 by six months from…
April 30, 2020 Glenmark Pharmaceuticals announced that it has received the Drugs Controller General (I) permission to conduct clinical trial on Favipiravir. As on date, Glenmark is the first pharmaceutical company in India to be given an approval by…
April 28, 2020 The International Coalition of Medicines Regulatory Authorities (ICMRA) on Tuesday has stated “We have stepped up our global collaboration to facilitate and expedite the development and evaluation of diagnostics and therapeutics, including possible vaccines, against SARS-CoV2”. ICMRA…
April 25, 2020 European Medicines Agency (EMA) has reminded again regarding serious side effects associated with the use of Chloroquine and Hydroxychloroquine in patients suffering from COVID-19. EMA in their bulletin has stated that “Chloroquine and hydroxychloroquine are known to…